Clinical Trials Sponsored by Emergent Product Development Seattle LLC
Total 14 results
-
Emergent Product Development Seattle LLCTerminatedMycosis Fungoides | Sezary SyndromeUnited States, Spain, France, Germany, Italy
-
PfizerEmergent Product Development Seattle LLCCompletedRheumatoid ArthritisUnited States, Canada
-
PfizerEmergent Product Development Seattle LLCCompletedActive Rheumatoid ArthritisUnited States, Canada, Serbia, Japan, Spain, Poland, Hungary, Argentina, Chile, Mexico
-
PfizerEmergent Product Development Seattle LLCCompletedLupus Erythematosus, SystemicUnited States
-
PfizerEmergent Product Development Seattle LLCCompletedArthritis, RheumatoidJapan
-
Wyeth is now a wholly owned subsidiary of PfizerEmergent Product Development Seattle LLCTerminated
-
Wyeth is now a wholly owned subsidiary of PfizerEmergent Product Development Seattle LLCTerminatedSystemic Lupus ErythematosusUnited States
-
GE HealthcarePharmaceutical Product Development, LLCCompletedCoronary Artery Disease (CAD)United States, Germany, Switzerland, Canada, Netherlands, France, Finland
-
Seattle Children's HospitalCompletedPain | Infant, Newborn, Diseases
-
Milliken Healthcare Products, LLCU.S. Army Medical Research and Development Command; Criterium, Inc.CompletedBurns | Skin Burn Requiring Skin GraftUnited States
-
Medical University of South CarolinaMerck Sharp & Dohme LLC; FDA Office of Orphan Products DevelopmentCompletedOsteoporosisUnited States
-
Medical University of South CarolinaMerck Sharp & Dohme LLC; FDA Office of Orphan Products DevelopmentCompletedFractures | Juvenile Osteoporosis | Low Bone DensityUnited States
-
Januario Castro, M.D.FDA Office of Orphan Products Development; Memgen, LLCTerminatedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Georgetown UniversityJohns Hopkins Bloomberg School of Public Health; United States Agency for International... and other collaboratorsRecruitingOral Pre-exposure Prophylaxis (PrEP) | Long-acting Injectable Cabotegravir for PrEPMalawi